Table 2.
Sample no. | 471 | 442 | 486 | 457 | 476 |
---|---|---|---|---|---|
Microscopy examination | Positive P. vivax | Positive P. vivax | Positive P. vivax | Positive P. vivax | Positive P. vivax |
Red decay area at test line | 631.10 | 846.20 | 826.30 | 907.39 | 857.67 |
Blue decay area at test line | 299.22 | 416.34 | 356.00 | 445.82 | 409.38 |
Red/blue ratio of clinical samples (ratio_cal) | 2.11 | 2.03 | 2.32 | 2.05 | 2.10 |
Estimated red/blue ratio at the red decay area (ratio_ref) | 1.63 | 1.88 | 1.86 | 1.94 | 1.89 |
LFA colour discrimination | Malaria positive, P. falciparum negative | Malaria positive, P. falciparum negative | Malaria positive, P. falciparum negative | Malaria positive, P. falciparum negative | Malaria positive, P. falciparum negative |
LFA results (pLDH: μg mL−1) | pLDH: 1.02 | pLDH: 1.63 | pLDH: 1.56 | pLDH: 1.86 | pLDH: 1.67 |
ELISA results (pLDH: μg mL−1; PfHRP2: ng mL−1) |
pLDH: 2.70 PfHRP2: negative |
pLDH: * PfHRP2: negative |
pLDH: * PfHRP2: 3.35 |
pLDH: * PfHRP2: negative |
pLDH: * PfHRP2: negative |
* > 5.00 μg mL−1 but < 20.00 μg mL−1